Correlation between the lactate dehydrogenase levels with laboratory variables in the clinical severity of sickle cell anemia in Congolese patients

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Mikobi, Tite Minga ^a   Tshilobo, Prosper Lukusa ^a   Aloni, Michel Ntetani ^a   Lelo, Georges Mvumbi ^a   Akilimali, Pierre Zalagile ^a   Muyembe Tamfum, Jean Jacques ^b   Race, Valérie ^c   Matthijs, Gert ^c   Mwamba, Jean Marie Mbuyi ^a  

^a UNIVERSITY OF KINSHASA   (Congo)

^b Institut National de Recherche en Sciences Biomédicales   (Congo)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; LACTATE DEHYDROGENASE; BIOLOGICAL MARKER;

ADULT; ARTICLE; ASEPTIC NECROSIS; ASYMPTOMATIC DISEASE; CHOLELITHIASIS; CONGOLESE (KINSHASA); CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HEMOGLOBIN ANALYSIS; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEG ULCER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; THROMBOCYTE COUNT; ADOLESCENT; BLOOD; CHILD; DEMOCRATIC REPUBLIC CONGO; MEAN CORPUSCULAR VOLUME;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BIOMARKERS; CHILD; DEMOCRATIC REPUBLIC OF THE CONGO; ERYTHROCYTE INDICES; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; PHENOTYPE;

EID: 84929224955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123568     Document Type: Article

References (47)

1. Rees DC, Williams TN, Gladwin MT (2010) Sickle cell disease. Lancet 376: 2018-2031. doi: 10.1016/S0140-6736(10)61029-X PMID: 21131035
2. Bower SA, Reid HL, Greenidge A, Landis C, Reid M (2013) Blood Viscosity and the Expression of Inflammatory and Adhesion Markers in Homozygous Sickle Cell Disease Subjects with Chronic Leg Ulcers. Plos One 8: e68929. doi: 10.1371/journal.pone.0068929 PMID: 23922670
3. Hatzipantelis ES, Pana ZD, Gombakis N, Taparkou A, Tzimouli V, Kleta D, et al. (2013) Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease. Int J Hematol 98:158-63. doi: 10.1007/s12185-013-1392-y PMID: 23807289
4. Connes P, Lamarre Y, Waltz X, Ballas SK, Lemonne N, Etienne-Julan M, et al. (2014) Haemolysis and abnormal haemorheology in sickle cell anaemia. Br J Haematol, 2014 Feb 24. doi: 10.1111/bjh.12786
5. Saraf SL, Zhang X, Kanias T, Lash JP, Molokie RE, Oza B, et al. (2014) Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br J Haematol 164:729-39. doi: 10.1111/bjh.12690 PMID: 24329963
6. Agasa B, Bosunga K, Opara A, Tshilumba K, Dupont E, Vertongen F, et al. (2010) Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy? Transfus Med 20:62-65. doi: 10.1111/j.1365-3148.2009.00943.x PMID: 19712051
7. Tshilolo L, Aissi LM, Lukusa D, Kinsiama C, Wembonyama S, Gulbis B, et al. (2009) Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. J Clin Pathol 62:35-38. doi: 10.1136/jcp.2008.058958 PMID: 19103857
8. Aloni MN, Nkee L (2014) Challenge of managing sickle cell disease in a pediatric population living in kinshasa, democratic republic of congo: a sickle cell center experience. Hemoglobin 38:196-200. doi: 10.3109/03630269.2014.896810 PMID: 24669956
9. Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN (2013) Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med 10:e1001484. doi: 10.1371/journal.pmed.1001484 PMID: 23874164
10. Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN (2011) Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med 41:S398-405. doi: 10.1016/j.amepre.2011.09.013 PMID: 22099364
11. Taylor JG 6th, Nolan VG, Mendelsohn L, Kato GJ, Gladwin MT, Steinberg MH (2008) Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One 3:e2095. doi: 10.1371/journal.pone.0002095 PMID: 18461136
12. Darbarin SD, Onyekweret O, Nouraie M, Minniti CP, Luchtman-Jones L, Rana S, et al. (2012) Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr 160: 286-290. doi: 10.1016/j.jpeds.2011.07.018 PMID: 21890147
13. Kato GJ, McGonan V, Machado RF, Little JA, Taylor J, Morris CR, et al. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 107: 2279-2285. PMID: 16291595
14. Stankovic Stojanovic K, Steichen O, Lefevre G, Bachmeyer C, Avellino V, Grateau G, et al. (2012) High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients. Clin Biochem. doi: 10.1016/j.clinbiochem.2012.07.114
15. Nolan VG, Adewoye A, Baldwin C, Wang L, Ma Q, Wyszynski DF, et al. (2006) Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br J Haematol 133: 570-578. doi: 10.1111/j.1365-2141.2006.06074.x PMID: 16681647
16. Bonds DR (2005) Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Rev 19:99-110. PMID: 15603913
17. Bhatnagar P, Purvis S, Barron-Casella E, DeBaun MR, Casella JF, Arking DE, et al. (2011) Genomewide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. J Hum Genet 56:316-23. doi: 10.1038/jhg.2011.12 PMID: 21326311
18. Smith WR, Coyne P, Smith VS, Mercier B (2003) Temperature changes, temperature extremes, and their relationship to emergency department visits and hospitalizations for sickle cell crisis. Pain Manag Nurs 4:106-11. PMID: 14566708
19. Cumming V, King L, Fraser R, Serjeant G, Reid M (2008) Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia. Br J Haematol 142: 119-125. doi: 10.1111/j.1365-2141.2008.07115.x PMID: 18477043
20. Tshilolo L, Summa V, Gregorj C, Kinsiama C, Bazeboso JA, Avvisati G, et al. (2012) Foetal haemoglobin, erythrocytes containing foetal haemoglobin, and hematological features in congolese patients with sickle cell anaemia. Anemia 2012:105349. doi: 10.1155/2012/105349 PMID: 22830000
21. De Montalembert M, Tshilolo L (2007) Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa?. Med Trop (Mars) 67:612-6. PMID: 18300525
22. Wembonyama S, Mpaka S, Tshilolo L (2007) Medicine and health in the Democratic Republic of Congo: from Independence to the Third Republic]. Med Trop (Mars). 67:447-57. PMID: 18225727
23. Ballas SK (2012) More definitions in sickle cell disease: steady state v base line data. Am J Hematol. 87:338. doi: 10.1002/ajh.22259 PMID: 22213235
24. Mpalampa L, Ndugwa CM, Ddungu H, Idro R (2012) Foetal haemoglobin and disease severity in sickle cell anaemia patients in Kampala, Uganda. BMC Blood Disord. 12:11. doi: 10.1186/1471-2326-12-11 PMID: 22958547
25. Omoti CE (2005) The value of foetal haemoglobin level in the management of Nigerian sickle cell anaemia patients. Niger Postgrad Med J. 12:149-54. PMID: 16160713
26. Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, et al. (2011) Fetal hemoglobin in sickle cell anemia. Blood 118:19-27. doi: 10.1182/blood-2011-03-325258 PMID: 21490337
27. Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, editors. Disorders of Hemoglobin: Genetics, Pathophysiology, Clinical Management (2nd ed). Cambridge, United Kingdom: Cambridge University Press; 2009.
28. Rodgers GP, Steinberg MH (2001) Pharmacologic treatment of sickle cell disease and thalassemia: the augmentation of fetal hemoglobin. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management (1st ed). Cambridge, United Kingdom: Cambridge University Press; p. 1028-1051. PMID: 12779271
29. Powars D, Weiss JN, Chan LS, Schroeder WA (1984) Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood. 63:921-6. PMID: 6200161
30. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al (1994)Mortality in sickle cell disease Life expectancy and risk factors for early death. N Engl J Med. 330:1639-44. PMID: 7993409
31. Mouélé R, Galactéros F, Feingold J (1999) Haemoglobin F (HbF) levels in sickle-cell anaemia patients homozygous for the Bantu haplotype. Eur J Haematol. 63:136-7. PMID: 10480294
32. Enosolease ME, Ejele OA, Awodu OA (2005) The influence of foetal haemoglobin on the frequency of vaso-occlusive crisis in sickle cell anaemia patients. Niger Postgrad Med J. 12:102-5. PMID: 15997258
33. Olaniyi JA, Arinola OG, Odetunde AB (2010) Foetal Haemoglobin (HbF) status in adult sickle cell anemia patients in Ibadan, Nigeria. Ann Ib Postgrad Med. 8:30-3. PMID: 25161472
34. Rahimi Z, Karimi M, Haghshenass M, Merat A (2003) Beta-globin gene cluster haplotypes in sickle cell patients from southwest Iran. Am J Hematol. 74:156-60. PMID: 14587041
35. Mukherjee MB, Surve RR, Gangakhedkar RR, Ghosh K, Colah RB, Mohanty D (2004) Beta-globin gene cluster haplotypes linked to the betaS gene in western India. Hemoglobin. 28:157-61. PMID: 15182059
36. Sakamato TM, Lanaro C, Ozelo MC, Garrido VT, Olalla-Saad ST, Conran N, et al. (2013) Increased adhesive and inflammatory properties in blood outgrowth endothelial cells from sickle cell anemia. Microvasc Res 90: 173-9. doi: 10:1016/jmvr.2013.10.002 PMID: 24144783
37. Canalli AA, Franco-Penteado CF, Saad ST, Conran N, Costa FF (2008) Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation. Haematologica 93:605-609. doi: 10.3324/haematol.12119 PMID: 18326523
38. Kasschau MR, Barabino GA, Bridges KR, Golan DE (1996) Adhesion of sickle neutrophils and erythrocytes to fibronectin. Blood 87:771-780. PMID: 8555502
39. Sebastiani P, Nolan VG, Baldwin CT, Abad-Grau MM, Wang L, Adewoye AH, et al. (2007) A network model to predict the risk of death in sickle cell disease. Blood 110:2727-35. PMID: 17600133
40. Dhaliwal G, Cornett PA, Tierney LM Jr (2004) Hemolytic anemia. Am Fam Physician 69:2599-606. PMID: 15202694
41. Maier-Redelsperger M, Flahault A, Neonato MG, Girot R, Labie D (2004) Automated analysis of mature red blood cells and reticulocytes in SS and SC disease. Blood Cells Mol Dis. 33:15-24. PMID: 15223005
42. Sawadogo D, Tolo-Dilkébié A, Sangaré M, Aguéhoundé N, Kassi H, Latte T. (2004) Influence of the Clinical Status on Stress Reticulocytes, CD 36 and CD 49d of SSFA 2 Homozygous Sickle Cell Patients Followed in Abidjan. Adv Hematol. 2014:273860. doi: 10.1155/2014/273860 PMID: 24715903
43. Browne PV, Hebbel RP (1996) CD36-positive stress reticulocytosis in sickle cell anemia. J Lab Clin Med. 127:340-7. PMID: 8656036
44. Ohno K, Tanaka H, Samata N, Jakubowski JA, Tomizawa A, Sugidachi A (2014) Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel. Thromb Res 134:889-94. doi: 10.1016/j.thromres.2014.07.035 PMID: 25130912
45. Frelinger AL 3rd, Jakubowski JA, Brooks JK, Carmichael SL, Berny-Lang MA, Barnard MR, et al. (2014) Platelet activation and inhibition in sickle cell disease (pains) study. Platelets. 25:27-35. doi: 10.3109/09537104.2013.770136 PMID: 23469943
46. Novelli EM, Kato GJ, Ragni MV, Zhang Y, Hildesheim ME, Nouraie M, et al. (2012) Plasma thrombos-pondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates. Am J Hematol 87:326-30. doi: 10.1002/ajh.22274 PMID: 22318901
47. Van der Land V, Peters M, Biemond BJ, Heijboer H, Harteveld CL, Fijnvandraat K. et al. (2013) Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease. Thromb Res 132:712-7. doi: 10.1016/j.thromres.2013.10.006 PMID: 24182550